Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a progressive, multisystemic disease in which affected patients frequently present with signs and symptoms misattributed to other disease states, leading to critical delays in diagnosis and treatment. Timely disease recognition and early intervention serve to mitigate and arrest the life-threatening systemic complications of the disease, and thus, are of paramount importance for improving patient outcomes. Tune in to hear expert faculty discuss the latest guideline recommendations and approaches to support an early and accurate diagnosis of ATTRv-PN. As part of this interactive session, you’ll explore evidence-based strategies for management of ATTRv-PN, including the latest clinical evidence on ATTRv-PN treatments, and practical tools you can adopt in your own clinical practice to individualize patient care. Download a Point-of-Care resource designed to support you and your clinical team in recognizing the signs and symptoms of ATTRv-PN and developing a comprehensive diagnostic and treatment plan.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/applying-latest-recommendations-detect-diagnose-treat-polyneuropathy
- Start Date: 2024-08-16 05:00:00
- End Date: 2024-08-16 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Alnylam - Amount: 37375.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all